WO2000036928A1 - Composition de complement alimentaire - Google Patents
Composition de complement alimentaire Download PDFInfo
- Publication number
- WO2000036928A1 WO2000036928A1 PCT/BE1999/000168 BE9900168W WO0036928A1 WO 2000036928 A1 WO2000036928 A1 WO 2000036928A1 BE 9900168 W BE9900168 W BE 9900168W WO 0036928 A1 WO0036928 A1 WO 0036928A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- supplement composition
- feed supplement
- fatty acids
- feed
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000006052 feed supplement Substances 0.000 title claims abstract description 39
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 55
- 239000000194 fatty acid Substances 0.000 claims abstract description 55
- 229930195729 fatty acid Natural products 0.000 claims abstract description 55
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 54
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 31
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 235000021588 free fatty acids Nutrition 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 12
- 235000000346 sugar Nutrition 0.000 claims description 6
- 150000008163 sugars Chemical class 0.000 claims description 6
- 239000013589 supplement Substances 0.000 claims description 5
- 229920002498 Beta-glucan Polymers 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 16
- 229940088710 antibiotic agent Drugs 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 241000282887 Suidae Species 0.000 description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000001079 digestive effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N noncarboxylic acid Natural products CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 230000002411 adverse Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- YKQOSKADJPQZHB-RGYSVOEGSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(6r,9s,12r,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydr Chemical compound CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C([C@@H](C)O)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O YKQOSKADJPQZHB-RGYSVOEGSA-N 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920000926 Galactomannan Polymers 0.000 description 2
- 239000006030 antibiotic growth promoter Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 208000003495 Coccidiosis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- -1 stearyl fatty acid Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
Definitions
- the present invention relates to a feed supplement composition as described in the preamble of the first claim.
- a feed supplement composition which comprised one or more fatty acids containing 6-10 carbon atoms
- the development of bacteria in the digestive tract of the young animal can be controlled. Most probably this effect can be explained by the fact that by the presence of these fatty acids in the stomach of the animal a physiological environment is created that is capable of regulating and stabilizing the gastro-intestinal microflora. It has been found that fatty acids containing 6-10 carbon atoms are capable of killing the majority of the pathological bacteria already in the stomach, so that the transit of pathological doses of bacteria towards the intestines can be prohibited and the occurrence of gastro-intestinal disorder prevented.
- fatty acids containing 6-10 carbon atoms have unexpectedly been found capable of markedly improving the growth rate of the animal.
- the observed growth promotion ability of fatty acids containing 6-10 carbon atoms appears to be comparable with the growth promotion effects obtainable with the known antibiotic growth promoters, without however showing the above described adverse side effects for the animal, the feed industry and the consumer.
- the growth promoting effect of the fatty acids containing 6-10 carbon atoms can be explained by their particular absorption from the digestive tract into the portal blood circulation system, as a consequence of which they constitute an energy source that is readily available to the animal.
- Fatty acids containing 6-10 carbon atoms namely form the main energy source for the development of mucosa and epithelial cells.
- a mixture of different fatty acids preferably use is made of a mixture of different fatty acids, the individual fatty acids containing a different number of carbon atoms.
- the inventors have found that such a mixture shows optimal antimicrobial properties. Also with such a mixture, the antimicrobial spectrum of the antibiotic growth promoters used in today's intensive animal production can be mimicked approximately completely. This is surprising.
- the feed supplement composition of the present invention preferably comprises a mixture of fatty acids, which contain 6-8 carbon atoms.
- the inventors have found that those fatty acids unexpectedly show the best antimicrobial properties and the most important growth rate enhancing effect.
- the fatty acids are preferably present in the supplement composition in an amount of 0.01-2 percent by weight with respect to the total weight of the feed supplement composition.
- the feed supplement composition of the present invention preferably contains an ammonium, a sodium, potassium or calcium salt of one or more of the free fatty acids, or a mixture of one or more of these salts, to prevent the composition from spreading an unpleasant odor which could restrain the animal from consuming it.
- a calcium salt of one or more of the fatty acids the addition of lime stone as a calcium source can at least partly be dispensed with.
- the sodium salt of the fatty acids has been found to be capable of increasing the resorption efficiency of the fatty acid by the digestive system. This allows either to lower the amount of fatty acid to be supplied or to further improve both the control of the microbial environment in the gastro-intestinal tract and the growth rate.
- the feed supplement composition of the present invention preferably comprises slowly fermentable sugars (called prebiotics), preferably in an amount of 0.5 to 1.5 percent by weight with respect to the total weight of the composition.
- prebiotics include slowly fermentable sugars for example galactomannans, for example guar gum, ⁇ -glucanes, transoligosaccharides, fructo- oligosaccharides and galacto-oligo-saccharides, but ⁇ -glucanes and galactomannans are preferred.
- Prebiotics have been found capable of inhibiting the attachment sites of pathogenic bacteria in the small and large intestine and in that way of lowering the pathogenic bacterial population at the end of the small intestine. Simultaneously they have been found capable of enhancing the development of bacteria in support of the well functioning of the large intestine, by counteracting reflux of pathogenic bacteria into the small intestine to a large extent.
- the fatty acids that can be used in the feed supplement of this invention include both fatty acids with an even and an odd number of carbon atoms, for example C6 (caproic acid, hexanoic acid), C7 (heptanoic acid), C8 (caprylic acid, octanoic acid), C9 (nonanoic or pelargonic acid) and C10 (capric acid, decanoic acid).
- C6 caproic acid, hexanoic acid
- C7 heptanoic acid
- C8 caprylic acid, octanoic acid
- C9 nonanoic or pelargonic acid
- C10 capric acid, decanoic acid
- the mechanism according to which the fatty acids exert antimicrobial activity has been well documented in literature.
- the currently accepted theory is that the lipid microbial cell membrane is permeable for the undissociated fatty acid, as a consequence of which the fatty acid is capable of passing across the microbial cell membrane towards the more alkaline interior.
- the fatty acid is dissociated, thus involving a decrease of the intracellular pH below the survival level.
- the fatty acid thus in fact acts as a protonophore, which increases inward leak of H + and involves that efflux of H + is too slow to allow the intracellular pH to be increased again.
- the physicochemical properties of the fatty acids which allow them to act as protonophores may vary and depend on numerous parameters.
- the feed supplement composition of the present invention is preferably used as a supplement for the feed of early weaned piglets, but is not limited thereto.
- the feed supplement composition of this invention is also suitable for use with other animals for example poultry or other types of animals, as well as other age categories of animals.
- the feed supplement composition of this invention can for example also be administered to sows, shortly before weaning of the piglets. In that way the fatty acids are administered to the piglets in an indirect manner and allow to prevent the development of pathogenic microorganisms in the stomach already before weaning.
- coccidioses which may involve Clos di ⁇ m spp. and necrotic enteritis, can be treated.
- the invention also relates to a feed composition
- a feed composition comprising the above described feed supplement composition, preferably in an amount of 10-30 percent by weight with respect to the total weight of the feed composition. Administration of such an amount allows to achieve an optimum growth performance .
- Example 1 Feed composition.
- a mixture according to this invention was prepared which contained approximately 40 parts by weight of barley, 14 parts by weight of wheat, 10 parts by weight of maize products, 11 parts by weight of Soya products and 20 parts by weight of a feed supplement composition containing 0.8 parts by weight of fatty acids with 8-10 carbon atoms.
- a control feed was prepared which contained the same components as the above described mixture, with the exception that the control feed did not contain fatty acids.
- Example 2 In vivo test with early weaned pigs.
- a group of 10 pigs have been weaned after a period of 21 days. All pigs had free access to water and feed.
- a first control group (group 1 ) was fed with the control feed.
- 10 8 pathogenic bacteria (E. coli K88) were added per g of feed.
- a second group (group 2) was fed with the feed composition of this invention as described in example 1.
- 10 8 pathogenic bacteria (E. coli K88) were added per g of feed.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Fodder In General (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU18509/00A AU1850900A (en) | 1998-12-22 | 1999-12-21 | Feed supplement composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP98/08531 | 1998-12-22 | ||
EP9808531 | 1998-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000036928A1 true WO2000036928A1 (fr) | 2000-06-29 |
Family
ID=8167179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BE1999/000168 WO2000036928A1 (fr) | 1998-12-22 | 1999-12-21 | Composition de complement alimentaire |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1850900A (fr) |
WO (1) | WO2000036928A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1294371A1 (fr) † | 2000-06-20 | 2003-03-26 | N.V. Seghers Nutrition Sciences S.A. | Acides gras a chaines moyennes utilisables comme agents antimicrobiens |
EP1314358A1 (fr) * | 2001-11-21 | 2003-05-28 | N.V. Seghers Nutrition Sciences | Composition antimicrobienne pour animaux |
JP2012131741A (ja) * | 2010-12-22 | 2012-07-12 | Bussan Biotech Kk | 細胞性免疫活性化剤及びその利用 |
CN103609853A (zh) * | 2013-12-12 | 2014-03-05 | 山东新希望六和集团有限公司 | 用于治疗猪胃溃疡的饲料及其制备方法 |
EP2381797B1 (fr) | 2009-01-23 | 2017-03-08 | Nutreco Nederland B.V. | Additif d'aliment de bétail et aliment de bétail comprenant des esters alcoyls d'acides gras de longueur de chaîne intermédiaire, et leur utilisation dans les aliments de bétail |
US10772343B2 (en) | 2014-11-19 | 2020-09-15 | Kansas State University Research Foundation | Chemical mitigants in animal feed and feed ingredients |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1309863A (en) * | 1970-10-08 | 1973-03-14 | Hydrierwerk Rodleben Veb | Supplement foodstuff for animals |
US4002775A (en) * | 1973-07-09 | 1977-01-11 | Kabara Jon J | Fatty acids and derivatives of antimicrobial agents |
EP0089376A1 (fr) * | 1981-09-18 | 1983-09-28 | MITSUI TOATSU CHEMICALS, Inc. | Additif d'alimentation ou produit d'alimentation |
EP0519458A1 (fr) * | 1991-06-17 | 1992-12-23 | Kao Corporation | Additif de fourrage et fourrage |
WO1997000018A1 (fr) * | 1995-06-14 | 1997-01-03 | Matforsk Norwegian Food Research Institute | Aliments pour animaux |
-
1999
- 1999-12-21 WO PCT/BE1999/000168 patent/WO2000036928A1/fr active Application Filing
- 1999-12-21 AU AU18509/00A patent/AU1850900A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1309863A (en) * | 1970-10-08 | 1973-03-14 | Hydrierwerk Rodleben Veb | Supplement foodstuff for animals |
US4002775A (en) * | 1973-07-09 | 1977-01-11 | Kabara Jon J | Fatty acids and derivatives of antimicrobial agents |
EP0089376A1 (fr) * | 1981-09-18 | 1983-09-28 | MITSUI TOATSU CHEMICALS, Inc. | Additif d'alimentation ou produit d'alimentation |
EP0519458A1 (fr) * | 1991-06-17 | 1992-12-23 | Kao Corporation | Additif de fourrage et fourrage |
WO1997000018A1 (fr) * | 1995-06-14 | 1997-01-03 | Matforsk Norwegian Food Research Institute | Aliments pour animaux |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1294371A1 (fr) † | 2000-06-20 | 2003-03-26 | N.V. Seghers Nutrition Sciences S.A. | Acides gras a chaines moyennes utilisables comme agents antimicrobiens |
EP1294371B2 (fr) † | 2000-06-20 | 2010-05-26 | Nutrition Sciences | Acides gras a chaines moyennes utilisables comme agents antimicrobiens |
EP1314358A1 (fr) * | 2001-11-21 | 2003-05-28 | N.V. Seghers Nutrition Sciences | Composition antimicrobienne pour animaux |
WO2003043441A1 (fr) * | 2001-11-21 | 2003-05-30 | Nutrition Sciences N.V. | Composition anti-microbienne pour animaux |
EP2381797B1 (fr) | 2009-01-23 | 2017-03-08 | Nutreco Nederland B.V. | Additif d'aliment de bétail et aliment de bétail comprenant des esters alcoyls d'acides gras de longueur de chaîne intermédiaire, et leur utilisation dans les aliments de bétail |
EP2381797B2 (fr) † | 2009-01-23 | 2023-05-31 | Nutreco Nederland B.V. | Additif d'aliment de bétail et aliment de bétail comprenant des esters alcoyls d'acides gras de longueur de chaîne intermédiaire, et leur utilisation dans les aliments de bétail |
JP2012131741A (ja) * | 2010-12-22 | 2012-07-12 | Bussan Biotech Kk | 細胞性免疫活性化剤及びその利用 |
CN103609853A (zh) * | 2013-12-12 | 2014-03-05 | 山东新希望六和集团有限公司 | 用于治疗猪胃溃疡的饲料及其制备方法 |
US10772343B2 (en) | 2014-11-19 | 2020-09-15 | Kansas State University Research Foundation | Chemical mitigants in animal feed and feed ingredients |
US10918118B2 (en) | 2014-11-19 | 2021-02-16 | Kansas State University Research Foundation | Chemical mitigants in animal feed and feed ingredients |
US11896035B2 (en) | 2014-11-19 | 2024-02-13 | Kansas State University Research Foundation | Chemical mitigants in animal feed and feed ingredients |
Also Published As
Publication number | Publication date |
---|---|
AU1850900A (en) | 2000-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11517551B2 (en) | Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals | |
EP3054783B1 (fr) | Composition d'acides gras à chaîne moyenne et aliment pour animaux enrichi avec cette composition | |
CN102892303B (zh) | 包含寡糖和中链脂肪酸的饲料添加剂 | |
JP5259905B2 (ja) | 抗菌剤として適用可能な中鎖脂肪酸 | |
EP2410871B1 (fr) | Compositions contenant des monoglycérides d'acide organique en c1 à c7 et du glycérol, leur préparation et leur utilisation en tant qu'antibactériens et agents anti-moisissures | |
CN105611841B (zh) | 包含中链脂肪酸的组合物和饲料 | |
NO143297B (no) | Dyrefor. | |
CN102291995A (zh) | 动物饲料添加剂与含有中链脂肪酸烷基酯的动物饲料以及它们在动物饲料中的应用 | |
JP3260111B2 (ja) | 鳥類の給餌中止時の体重減少抑制方法及び腸内有害細菌減少方法 | |
BE1013997A6 (nl) | Antimicrobiele samenstelling voor dieren. | |
CN111903849A (zh) | 一种替代抗生素的饲料添加剂及其制造方法 | |
CN100536677C (zh) | 含有乳酸或其衍生物和无机酸的混合物的抗微生物组合物 | |
EP1765318A2 (fr) | Acides gras a chaine moyenne pouvant etre utilises comme agents antimicrobiens | |
WO2000036928A1 (fr) | Composition de complement alimentaire | |
CS253570B2 (en) | Fodder ingredient | |
WO2001028551A1 (fr) | Agents favorisant l'engraissement d'animaux et procede favorisant l'engraissement | |
RU2517745C2 (ru) | Способ выращивания цыплят-бройлеров | |
JP2006516278A (ja) | 腸内細菌叢の組成の改善のためのスフィンゴ脂質 | |
US6221404B1 (en) | Method for improving the efficacy of a probiotic, preparation of food additives and animal feed containing same | |
KR20010077679A (ko) | 가축사료 첨가제용 조성물 | |
RU2832334C1 (ru) | Способ кормления бройлеров в условиях теплового стресса | |
RU2795853C1 (ru) | Способ повышения продуктивных качеств цыплят-бройлеров | |
SU1423093A1 (ru) | Способ получени комбикорма | |
JPS637737B2 (fr) | ||
RU2060685C1 (ru) | Способ кормления животных с однокамерным желудком |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |